This is consistent with the fact that activation of the AKT axis is pro-survival in CLL (Chapman et al. 2017; Zhuang et al. 2010) and thus, AKT-S could represent a compartment of CLL cases with more aggressive disease. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.